发明名称 |
Kinase inhibitor |
摘要 |
There is provided a compound of formula I,;
which compound has antiinflammatory activity (e.g. through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases, e.g., Src and Lck) and has use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines. |
申请公布号 |
US8927563(B2) |
申请公布日期 |
2015.01.06 |
申请号 |
US201414242531 |
申请日期 |
2014.04.01 |
申请人 |
Respivert Limited;Topivert Pharma Limited |
发明人 |
Fyfe Matthew Colin Thor |
分类号 |
C07D239/47;A61K31/506;A61K31/5377;C07D211/86;A61K31/44;C07D405/12;C07D405/14;A61K31/444;A61K31/4427;A61K31/505;A61K31/541;A61K31/551;A61K31/553;C07C311/08;C07D403/12;C07D213/74;C07D401/12;C07D413/12 |
主分类号 |
C07D239/47 |
代理机构 |
Knobbe, Martens, Olson & Bear, LLP |
代理人 |
Knobbe, Martens, Olson & Bear, LLP |
主权项 |
1. A compound of formula I, or a pharmaceutically acceptable salt thereof. |
地址 |
Buckinghamshire GB |